XOMA Royalty (XOMA) Return on Assets Growth (3y) (2014 - 2026)

XOMA Royalty (XOMA) Return on Assets Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,184.45 Bn 68,184.17 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 474.39 Bn 469.59 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.45 Bn 116.21 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.92 Bn 61.16 Bn 3.31 Bn
7 Belite Bio 63.43 Bn 63.43 Bn -
8 Argenx Se 56.67 Bn 51.49 Bn 1.41 Bn
9 Revolution Medicines 38.08 Bn 38.08 Bn -
10 XOMA Royalty 478.42 Mn 412.34 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00